FDA OKs Bunavail for Induction of Opioid Addiction Treatment FDA OKs Bunavail for Induction of Opioid Addiction Treatment

The FDA has broadened the indication for Bunavail (buprenorphine and naloxone) buccal film to include induction of buprenorphine treatment for opioid dependence.FDA Approvals
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Pharmacist News Alert Source Type: news